Cardiac resynchronization therapy (CRT) is an accepted treatment for patients with heart
failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. It has been …

More than 2 decades of research has established the role of cardiac resynchronization
therapy (CRT) in medically refractory, mild to severe systolic heart failure (HF) with abnormal …

Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart
failure (HF) patients. Cumulated knowledge on the pathophysiological mechanisms …

Cardiac resynchronization therapy (CRT) has been used extensively over the last years in
the therapeutic management of patients with end-stage heart failure. Data from 4,017 …

Background Cardiac resynchronization therapy (CRT) is one of the most exciting recent
advancements in heart failure (HF) treatment. Methods This review surveys the available …

Cardiac resynchronization therapy (CRT) improves survival, symptoms, quality of life,
exercise capacity, and cardiac structure and function in patients with New York Heart …

Objectives: We sought to determine the effects of cardiac resynchronization therapy (CRT) in
New York Heart Association (NYHA) functional class II heart failure (HF) and NYHA …

Heart failure continues to be a major public health problem with high morbidity and mortality
rates, despite the advances in medical treatment. Advanced heart failure patients have …

Cardiac resynchronization therapy (CRT) is an established adjunctive treatment for patients
with systolic heart failure (HF) and ventricular dyssynchrony. The majority of recipients …

Cardiac resynchronization therapy (CRT), or biventricular pacing, has become a standard
therapeutic modality for patients with symptomatic heart failure (HF), depressed left …